Cysteamine ophthalmic Pregnancy and Breastfeeding Warnings
Cysteamine ophthalmic is also known as: Cystaran
Cysteamine ophthalmic Pregnancy Warnings
FDA pregnancy category: C Potential benefit should outweigh the potential risk.
Animal studies have shown cysteamine to be teratogenic and fetotoxic at oral doses of 0.2 to 0.7 times the recommended human maintenance dose on a body surface basis. Teratogenic findings included cleft palate, kyphosis, heart ventricular septal defects, microcephaly, and exencephaly. Fetotoxicity resulted in intrauterine death and growth retardation. In addition, reduced animal fertility and survival of offspring was observed at oral doses 1.7 times the recommended human dose based on body surface area. There are no controlled data in human pregnancy. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Cysteamine ophthalmic Breastfeeding Warnings
A decision should be made to discontinue breast-feeding or discontinue the drug, taking into account the importance of the drug to the mother. Excreted into human milk: Unknown Excreted into animal milk: Yes The effects in the nursing infant are unknown.
- cysteamine Ophthalmic Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.